This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Fecal incontinence, also known as bowel incontinence, is the inability to control the passing of stool or gas from the rectum. It can range from an occasional leakage of stool or gas to a complete loss of bowel control. Fecal incontinence is a common problem that affects people of all ages and genders, though it is most common among older adults and women. It can be caused by a number of factors such as nerve or muscle damage, anal sphincter dysfunction, or pelvic floor weakness. Treatment for fecal incontinence typically begins with lifestyle changes such as diet modifications, avoiding constipation, and exercise. Medications may also be used to reduce diarrhoea and increase muscle strength in the rectum. In more severe cases, surgery may be an option to repair damaged muscles or nerves. For those living with fecal incontinence, there are strategies to help manage the condition. It is important to maintain good hygiene to help prevent infection and to wear absorbent products to protect clothing. Other strategies include learning to recognize the sensation of stool arrival and using relaxation techniques to help with bowel control. Fecal incontinence can have a significant impact on quality of life. It can be embarrassing and cause anxiety and depression. It is important to talk to a healthcare provider if you are experiencing any signs of fecal incontinence. With the right treatment, it is possible to control symptoms and improve quality of life.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States